Menu
GWAS Study

Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.

McLaren PJ, Coulonges C, Ripke S et al.

23935489 PubMed ID
GWAS Study Type
13581 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

MP
McLaren PJ
CC
Coulonges C
RS
Ripke S
VD
van den Berg L
BS
Buchbinder S
CM
Carrington M
CA
Cossarizza A
DJ
Dalmau J
DS
Deeks SG
DO
Delaneau O
DL
De Luca A
GJ
Goedert JJ
HD
Haas D
HJ
Herbeck JT
KS
Kathiresan S
KG
Kirk GD
LO
Lambotte O
LM
Luo M
MS
Mallal S
VM
van Manen D
MJ
Martinez-Picado J
ML
Meyer L
MJ
Miro JM
MJ
Mullins JI
ON
Obel N
OS
O'Brien SJ
PF
Pereyra F
PF
Plummer FA
PG
Poli G
QY
Qi Y
RP
Rucart P
SM
Sandhu MS
SP
Shea PR
SH
Schuitemaker H
TI
Theodorou I
VF
Vannberg F
VJ
Veldink J
WB
Walker BD
WA
Weintrob A
WC
Winkler CA
WS
Wolinsky S
TA
Telenti A
GD
Goldstein DB
DB
de Bakker PI
ZJ
Zagury JF
FJ
Fellay J
Chapter II

Abstract

Summary of the research findings

Multiple genome-wide association studies (GWAS) have been performed in HIV-1 infected individuals, identifying common genetic influences on viral control and disease course. Similarly, common genetic correlates of acquisition of HIV-1 after exposure have been interrogated using GWAS, although in generally small samples. Under the auspices of the International Collaboration for the Genomics of HIV, we have combined the genome-wide single nucleotide polymorphism (SNP) data collected by 25 cohorts, studies, or institutions on HIV-1 infected individuals and compared them to carefully matched population-level data sets (a list of all collaborators appears in Note S1 in Text S1). After imputation using the 1,000 Genomes Project reference panel, we tested approximately 8 million common DNA variants (SNPs and indels) for association with HIV-1 acquisition in 6,334 infected patients and 7,247 population samples of European ancestry. Initial association testing identified the SNP rs4418214, the C allele of which is known to tag the HLA-B*57:01 and B*27:05 alleles, as genome-wide significant (p = 3.6 × 10⁻¹¹). However, restricting analysis to individuals with a known date of seroconversion suggested that this association was due to the frailty bias in studies of lethal diseases. Further analyses including testing recessive genetic models, testing for bulk effects of non-genome-wide significant variants, stratifying by sexual or parenteral transmission risk and testing previously reported associations showed no evidence for genetic influence on HIV-1 acquisition (with the exception of CCR5Δ32 homozygosity). Thus, these data suggest that genetic influences on HIV acquisition are either rare or have smaller effects than can be detected by this sample size.

6,334 European ancestry cases, 7,247 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

13581
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S., Australia, Italy, Netherlands, France, Denmark, Uganda
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.